Corcept Therapeutics Inc. CORT
$116.10
-2.03%
at last close
Financials (TTM)
- Revenue
- $741.17 million
- Net Income
- $106.11 million
- Net Margin
- 14.32%
- Return on Equity
- 16.79%
- Debt-to-Equity
- —
- P/E Ratio
- 133.45
- Price / Book
- 19.86
- Price / Sales
- 16.93
Over the trailing twelve months, Corcept Therapeutics Inc. generated revenue of $741.17 million and net income of $106.11 million, a net margin of 14.32%.
At the last closing price of $116.10, CORT trades at 133.45 times trailing earnings and 16.93 times sales, with a market capitalization of $12.55 billion.
Key Stats
- Last Close
- $116.10
- Market Cap
- $12.55 billion
- 52-Week Range
- $28.66 – $126.38
- Average Volume
- 1.42 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.